Do analysts expect jaguar health (jagx) stock to rise?
Apr 01, 2022 · Jaguar Health's stock was trading at $1.35 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, JAGX stock has decreased by 57.0% and is now trading at $0.5799. View which stocks have been most impacted by COVID-19.
What is the jagx stock split?
Sep 30, 2019 · We wouldn't blame Jaguar Health, Inc. (NASDAQ:JAGX) shareholders if they were still in shock after the stock dropped like a lead balloon, …
What does jagx stand for?
Find the latest Jaguar Health, Inc. (JAGX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Is jaguar health stock down 98% for the year?
Apr 06, 2022 · The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -38.57% during the next 3 months and, with a 90% probability hold a price between $0.16 and $0.43 at the end of this 3-month period. Do note, that if the stock price manages to stay at …
Why did JAGX stock drop today?
Jaguar Health (JAGX) stock fell amid panic selling after the company announced a 1-for-3 reverse stock split, which was approved by majority of common stock shareholders in December 2020. Shares of the company were trading lower -18.96% to $0.94 a share on Tuesday.Sep 7, 2021
Is JAGX a good buy?
Valuation metrics show that Jaguar Animal Health, Inc. may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of JAGX, demonstrate its potential to underperform the market.
What is the future of JAGX stock?
Stock Price Forecast The 2 analysts offering 12-month price forecasts for Jaguar Health Inc have a median target of 5.88, with a high estimate of 6.75 and a low estimate of 5.00. The median estimate represents a +926.74% increase from the last price of 0.57.
Will JAGX grow?
High Growth Earnings: JAGX is forecast to remain unprofitable over the next 3 years. Revenue vs Market: JAGX's revenue (47.1% per year) is forecast to grow faster than the US market (8.5% per year). High Growth Revenue: JAGX's revenue (47.1% per year) is forecast to grow faster than 20% per year.
What happened to Jaguar health Stock?
In the last 12 months, the company's share price has declined 90%, including an 80% retrenchment over the past six months. Shares closed yesterday at 93 cents, putting them deep in penny stock territory.Jan 12, 2022
Will CEI stock go up?
Based on the algorithm-based CEI price prediction from Wallet Investor as of 22 March, the price of Camber Energy in the near term could rise to $1.14 per share by 4 April 2022. However, the service predicted that the stock could end the year at $0.Mar 22, 2022
Is ViewRay a good stock to buy?
ViewRay has received a consensus rating of Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.
What's the price of Jaguar health?
$ 0.5935CloseChgChg %$0.59610.054610.08%
What does Jaguar health do?
Jaguar Health, Inc. is a commercial stage pharmaceutical company. The Company is focused on developing plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with gastrointestinal (GI) distress, including chronic and debilitating diarrhea.
What is NAKD stock?
Cenntro Electric Group Ltd (NAKD)Jan 13, 2022
What is the stock symbol for Jaguar?
JAGXJaguar Health Inc JAGX:NASDAQ.
Is Jaguar Health a buy right now?
1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Jaguar Health in the last year. There are currently 1 bu...
How has Jaguar Health's stock been impacted by Coronavirus?
Jaguar Health's stock was trading at $1.35 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization....
Are investors shorting Jaguar Health?
Jaguar Health saw a drop in short interest in February. As of February 28th, there was short interest totaling 1,660,000 shares, a drop of 56.2% fr...
When is Jaguar Health's next earnings date?
Jaguar Health is scheduled to release its next quarterly earnings announcement on Monday, May 16th 2022. View our earnings forecast for Jaguar Hea...
How were Jaguar Health's earnings last quarter?
Jaguar Health, Inc. (NASDAQ:JAGX) announced its quarterly earnings results on Wednesday, November, 17th. The biotechnology company reported ($0.27)...
When did Jaguar Health's stock split? How did Jaguar Health's stock split work?
Shares of Jaguar Health reverse split before market open on Wednesday, September 8th 2021. The 1-3 reverse split was announced on Wednesday, Septem...
What price target have analysts set for JAGX?
1 brokers have issued 12-month price targets for Jaguar Health's stock. Their forecasts range from $5.00 to $5.00. On average, they expect Jaguar H...
Who are Jaguar Health's key executives?
Jaguar Health's management team includes the following people: Lisa A. Conte , President, Chief Executive Officer & Director Carol R. Lizak , Ch...
Who are some of Jaguar Health's key competitors?
Some companies that are related to Jaguar Health include Clearside Biomedical (CLSD) , TherapeuticsMD (TXMD) , TFF Pharmaceuticals (TFFP) , Imp...
Signals & Forecast
Support, Risk & Stop-loss
Furthermore, there is a buy signal from the 3 months Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Jaguar Health, Inc.
Is Jaguar Health, Inc. stock A Buy?
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
Executive Summary
Jaguar Health, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Share Price & News
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. More Details
Valuation
How has Jaguar Health's share price performed over time and what events caused price changes?
Future Growth
Is Jaguar Health undervalued compared to its fair value and its price relative to the market?
Dividend
How is Jaguar Health forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Management
What is Jaguar Health current dividend yield, its reliability and sustainability?
Ownership
How experienced are the management team and are they aligned to shareholders interests?
How do I buy Jaguar Health (JAGX) stock?
Who are the major shareholders and have insiders been buying or selling?
Who are Jaguar Health's (JAGX) competitors?
You can purchase shares of Jaguar Health ( NASDAQ: JAGX) through any online brokerage.
What is the target price for Jaguar Health (JAGX) stock?
Other companies in Jaguar Health’s space includes: Xeris Pharmaceuticals ( NASDAQ: XERS), Satsuma Pharmaceuticals ( NASDAQ: STSA), SCYNEXIS ( NASDAQ: SCYX), Tricida ( NASDAQ: TCDA) and Longboard Pharmaceuticals ( NASDAQ: LBPH).
Current Stock Price for Jaguar Health (JAGX)?
The latest price target for Jaguar Health ( NASDAQ: JAGX) was reported by Cantor Fitzgerald on July 7, 2021. The analyst firm set a price target for 5.00 expecting JAGX to rise to within 12 months (a possible 325.53 % upside ). 1 analyst firms have reported ratings in the last year.
When is Jaguar Health (NASDAQ:JAGX) reporting earnings?
The stock price for Jaguar Health ( NASDAQ: JAGX) is $ 1.175 last updated Today at 3:53:00 PM.
What sector and industry does Jaguar Health (JAGX) operate in?
Jaguar Health’s Q3 earnings are confirmed for after-market on November 15, 2021.
What is Jaguar Health?
Jaguar Health is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.
How much is Mytesi worth?
Source: Shutterstock. Importantly, Jaguar Health is a California-based biopharmaceutical firm focused on treating gastrointestinal conditions in animals and humans. And importantly, Jaguar Health largely focuses on commercial-stage medications. Right now, the company focuses on two drugs.
Is Mytesi approved for HIV?
Earlier this morning, Jaguar Health announced it had signed a royalty agreement for Mytesi worth $6 million. As a result, the lender will receive twice the purchase price of future royalties of Mytesi.
